CBD Therapy Seeds

Genetics & effects

CBD Therapy is a feminised cultivar listed with a balanced 50% sativa and 50% indica profile. Its specific parentage is not established in the available catalogue details, so the balanced classification is the most useful reference point for comparisons.

Reported cannabinoid figures place CBD at 10–14% and THC at 0.3–0.5%. These percentages are catalogue specifications rather than guaranteed measurements, and expression may vary between individual plants and growing environments. The cultivar name does not establish a cannabinoid ratio beyond these stated ranges.

People may subjectively describe the experience as calming, happy and relaxed. Effects are personal and can differ considerably. The flavour profile is characterised as fruity and sweet, while the listed terpenes are humulene and linalool. Together, these details offer a concise sensory reference without implying that every plant or experience will be identical.

Explore feminised seeds, cbd seeds, the Australian grow guide, and the planting calendar.

Growing in

CBD Therapy is classified as a beginner-level cultivar and is associated with temperate conditions. This is a broad catalogue description, not confirmation that it will suit every Australian location. Coastal exposure, elevation, humidity and local weather patterns can create substantial differences even within generally temperate areas.

In Australia, spring runs from September to November, summer from December to February, autumn from March to May and winter from June to August. These seasons provide a useful comparison framework, but local conditions and seasonal shifts remain more important than calendar labels alone. No indoor or outdoor height range has been established.

Indoor

The reported indoor yield is 400–500 g/m². This figure should be read as a catalogue range that may vary rather than an expected result. Available space, environmental consistency and general plant management can all influence development, while the unspecified height means growers cannot rely on a published stature when comparing layouts.

The listed flowering duration is 8–10 weeks. This refers only to the flowering phase; it is not the cultivar’s complete life cycle and should not be presented as the full period from germination to harvest.

Outdoor

The reported outdoor yield is 500–550 g/plant, again presented as a variable catalogue figure rather than a guarantee. The temperate climate classification gives a general point of comparison, but it does not establish suitability for a specific state, territory or microclimate.

Outdoor performance can be shaped by changing rainfall, humidity, wind and seasonal transitions. Because no outdoor height figure is available, comparisons should focus on the established flowering, yield, cannabinoid and sensory specifications rather than assumed plant size.

Harvest

Harvest assessment should reflect plant development rather than an invented calendar date. The supplied information establishes an 8–10 week flowering range but does not provide a complete cultivation timeline or a specific Australian harvest window. Regional seasonal variation means timing may differ from one setting to another.

For cultivar comparison, CBD Therapy is best summarised by its balanced sativa-indica classification, beginner difficulty rating, fruity-sweet profile, listed terpenes and reported yield ranges. All figures remain descriptive catalogue specifications and may vary in practice.